CDH22 and breast cancer: In order to examine the CDH22 expression pattern in BC, we measured its protein level by immunohistochemistry in a series of 88 BC cases and their adjacent-to-tissue counterparts, along with 24 non-neoplastic samples from reduction mammoplasties.